Development of a Conservative Care and Bracing Registry (CCBR)
CCBR
1 other identifier
observational
280
1 country
1
Brief Summary
Idiopathic scoliosis (IS) is a common problem affecting approximately 3% of the population; its progression can lead to significant health problems. The BrAIST study proved brace effectiveness, which increased bracing interest and utilization globally. There is a lack of evidence-based guidelines for brace treatment. There is significant variability in the brace literature with little consistency in indications for brace treatment goals, brace types, use of monitors, timing of radiographs, and evaluation of skeletal maturity. This lack of evidence demonstrates a clear need for a multi-center brace registry. The first aim of this proposal is to develop a comprehensive retrospective brace registry. This project involves expert clinicians, researchers and an orthotist, each with broad clinical and research experience in the field of bracing for scoliosis. The retrospective registry will function as a pilot, providing strategies to optimize variables, streamline data collection and minimize missing data. The next step will be to develop and launch a multicenter, prospective brace registry and Quality Improvement registry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedFirst Submitted
Initial submission to the registry
February 18, 2026
CompletedFirst Posted
Study publicly available on registry
April 14, 2026
CompletedApril 14, 2026
April 1, 2026
1.3 years
February 18, 2026
April 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Surgery
proportion of subjects ending growth with curves exceeding 50 Cobb degrees and needing surgery compared to proportion of subjects ending around the healthy threshold (30 Cobb degrees) with those in between.
Minimum of 2 years from baseline, corresponding to the first brace delivery, through end of growth. End of growth is defined by bone maturity evaluation (Risser >3 Sanders>6).
Cobb angle
The Cobb angle is the measure of the Curve magnitude. It is a continuous measure that changes over time. It will be considered as a continuous measure in panel data format or as a difference from baseline to the end of follow up. Clinically meaningful changes must exceed the measurment error which is 5 Cobb degrees.
Time Frame: Minimum of 2 years from baseline, corresponding to the first brace delivery, through end of growth. End of growth is defined by bone maturity evaluation (Risser >3 Sanders>6).
Eligibility Criteria
Scoliosis subjects treated with brace provided by a single orthotist clinic which provided highly specialised braces managed according to different protocols.
You may qualify if:
- All scoliosis type included
You may not qualify if:
- prior brace treatment or missing baseline information or missing information not allowing any comparisons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National scoliosis center
Fairfax, Virginia, 22031, United States
Related Links
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
February 18, 2026
First Posted
April 14, 2026
Study Start
June 30, 2024
Primary Completion
November 1, 2025
Study Completion
November 1, 2025
Last Updated
April 14, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
The data belongs to a study group association so sharing the data will require the approval of all members of this study group.